Startup Funding Tracker
Home›Companies›Biotech & Pharma›Renibus Therapeutics

Renibus Therapeutics, Inc.

Biotech & Pharma
Updated Oct 27, 2026·Latest SEC filing Jul 17, 2025·Suggest an edit

About Renibus Therapeutics

Renibus Therapeutics is a private company based in Southlake, Texas. It has reported $180,141,676 raised in five offerings on Form D since February 2016. Its chief executive is D. Keyser.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 25, 2023Jun 9, 2023amended Jul 17, 2025$110,895,239fully sold59$1.8MEquity, Options, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Jul 15, 2022Jul 29, 2022amended Aug 22, 2022$23,413,102of $25.0M target18$1.3MOptions, Securities on exercise, Simple Agreement for Future Equity ("SAFE")Rule 506(b)Form D/A ↗1 earlier filing
Sep 12, 2019Sep 23, 2019amended Feb 18, 2022$34,614,335fully sold30$1.1MEquity, Securities on exerciseRule 506(b)Form D/A ↗3 earlier filings
Feb 10, 2016Feb 24, 2016amended May 2, 2016$10,919,000of $12.5M target112$97,491EquityRule 506(b)Form D/A ↗3 earlier filings
Feb 9, 2016Feb 23, 2016$300,000fully sold4$75,000EquityRule 506(b)Form D ↗
Total, five offerings$180,141,676

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Renibus Therapeutics's Form D filed Jul 17, 2025.

JD
Jamie Donadio
Executive officer
BS
Bhupinder Singh
Executive officer and director
CG
DK
D. Keyser
Chief Executive Officer and director
HR

Earlier filings also listed Frank Stonebanks (executive officer and director, last listed Aug 2022), Alvaro Guillem (chairman of the board, last listed Feb 2022), Nels Bergmark (treasurer, last listed May 2016), Jocelyn Keyser (director, last listed May 2016), Jennifer Rasmussen (director, last listed May 2016), Harpreet Kaur (executive officer and director, last listed May 2016) and Dale Jones (director, last listed May 2016).

Sources

  1. SECRenibus Therapeutics, Inc. Form D/A, filed Sep 18, 2023
  2. SECRenibus Therapeutics, Inc. Form D, filed Jun 9, 2023
  3. SECRenibus Therapeutics, Inc. Form D, filed Jul 29, 2022
  4. SECRenibus Therapeutics, Inc. Form D/A, filed Jul 15, 2020
  5. SECRenibus Therapeutics, Inc. Form D/A, filed Nov 19, 2019
  6. SECRenibus Therapeutics, Inc. Form D, filed Sep 23, 2019
  7. SECRenibus Therapeutics, Inc. Form D/A, filed Apr 12, 2016
  8. SECRenibus Therapeutics, Inc. Form D/A, filed Mar 23, 2016
  9. SECRenibus Therapeutics, Inc. Form D, filed Feb 24, 2016
  10. SECRenibus Therapeutics, Inc. filing history